Introduction
============

The molecular basis of phenotypic divergence between species and populations is still far from being fully understood. In particular, within short evolutionary time scales, changes in gene expression play crucial roles in the diversification of phenotypical traits ([@evz131-B8]; [@evz131-B59]; [@evz131-B3]). Alterations in gene expression are mainly caused by sequence variations in the promoter regions of genes (*cis*-changes) or in the factors that regulate the expression of other genes (*trans*-changes). Gene regulatory factors (GRFs) include proteins that bind directly to DNA ([@evz131-B91]), cofactors that bind to transcription factors (TFs) bound to DNA, and histone modifying enzymes ([@evz131-B40]). Another type of regulatory molecules, noncoding RNAs, also plays a role in gene regulation ([@evz131-B102]). Variations in the expression levels, timing, and tissue-specificity coupled with sequence and structural changes in GRFs are important components of the genotype--phenotype map ([@evz131-B17]).

Several studies have already investigated *cis*-changes among primates and anatomically modern human (AMH), suggesting that a substantial fraction of the phenotypic differences we observe across species is probably explained by specific variation in gene regulatory mechanisms ([@evz131-B96]; [@evz131-B92]; [@evz131-B39]; [@evz131-B63]). GRF changes have also been documented in primates, demonstrating that some classes of GRFs have rapidly expanded and evolved in the human lineage ([@evz131-B59]; [@evz131-B47]; [@evz131-B23]; [@evz131-B99]). For instance, zinc-finger (ZNF) genes with a *Krüppel*-associated box (KRAB-ZNF), a subclass of C2H2 ZNF genes, have undergone different evolutionary processes than other non-KRAB C2H2 genes. These processes include in situ tandem duplications that resulted in an extensive expansion of KRAB-ZNF genes in mammals and a broad repertoire of lineage-specific genes, paralog diversification through positive selection and changes in the DNA-binding specificity of the ZNF arrays, and an excess of rapidly evolving genes in primate species ([@evz131-B27]; [@evz131-B30]; [@evz131-B18]; [@evz131-B44]). Several KRAB-ZNF genes are considered to be human-specific ([@evz131-B58]). Other KRAB-ZNFs exhibit functional differences in their DNA-binding domains between humans and chimpanzees ([@evz131-B59]) Further, ZNF genes associated with adaptive mechanisms to downregulate inherited endogenous retroelements in humans have been described ([@evz131-B77]; [@evz131-B32]; [@evz131-B47]). The rapid evolution of several GRFs in the primate lineage ([@evz131-B59]; [@evz131-B47]; [@evz131-B23]; [@evz131-B99]) suggests that GRFs may also exhibit elevated differentiation across human populations and potentially contribute to local adaptation.

Genes that control the adaptation of phenotypes to environmental fluctuations are subject to positive selection. Several candidate genes that were likely target of natural selection in humans have already been identified ([@evz131-B72]; [@evz131-B54]; [@evz131-B64]; [@evz131-B301]). However, a detailed exploration of how natural selection might have influenced the diversity of GRF genes and contributed to human phenotypic variation and local adaptation has not been attempted yet. In this study, we analyzed signatures of positive selection in several classes of GRFs in three human populations. We also tested whether these functional classes exhibit significant differences with respect to their past exposure to positive selection. To this end, we built a comprehensive catalog of human genes coding for proteins involved in transcriptional regulation by including and manually curating information from existing databases and inventories. Our results show that genes coding for GRFs are overrepresented in genomic regions associated with a signal of positive selection. We also found that many KRAB-ZNF gene clusters exhibit reduced genetic variation and extended haplotype homozygosity (EHH) at population-specific level. Leveraging available functional information and genetic variation from European and Asian populations allowed us to generate testable hypotheses on reasons for the higher prevalence of schizophrenia outside Europe. In addition, a similar analysis between European, Asian, African, Iberian, and Latin American populations, as well as archaic humans, support the potential roles of a human-specific KRAB-ZNF gene in developmental changes of the eye and adaptation to high/low ultraviolet (UV) exposure. Our examples also provide insights into how genetic variation might subtly tweak GRFs' binding affinity and their regulatory activity, thus allowing for population-specific phenotypic variation.

Materials and Methods
=====================

Building the GRF Gene Catalog
-----------------------------

We put together GRF genes from seven different lists previously published for humans. These gene sets included TF transcriptome and sequence evolution studies, TF inventories ([@evz131-B51]; [@evz131-B81]; [@evz131-B70]; [@evz131-B59]; [@evz131-B14]; [@evz131-B78]), and functional classifications ([@evz131-B91]) ([supplementary table S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Producing the GRF catalog reported here, which contains 3,344 out of 28,026 genes from the human genome (Hg19), involved multiple strategies (see [supplementary material, Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Identifying Candidate GRFs for Selection in Three AMHs Populations
------------------------------------------------------------------

Using whole genome sequencing data from 1000G project ([@evz131-B1]) and the data from 1000 Genomes Selection Browser 1.0 ([@evz131-B68]), we identified candidate genomic regions that exhibit genetic variation agreeable with signatures of positive selection. We mainly explored three AMHs populations: Utah Residents with Northern and Western European Ancestry (CEU), Han Chinese in Bejing (CHB), and Yoruba in Ibadan (YRI). We considered that the samples from these three human populations sufficiently represent broader geographical regions of ancestry, as suggested by [@evz131-B45]. To better understand how natural selection may have shaped the diversity we currently observe for GRF genes in these three different human populations, we first analyzed the results obtained from three different methods (CLR, XP-CLR, and XP-EHH) for detecting positive selection in three human populations ([@evz131-B68]). As additional strategy to complement our findings, we also included the *F*~ST~ statistics; a test for measuring population genetic differentiation. The data cover 83% of the GRF genes we cataloged, whereas for the remnant 17% there was not information available.

By using ranked score values based in the genome-wide distribution obtained for each population ([@evz131-B68]), and considering the complexity of human demography, we defined as candidates for positive selection all GRFs located in the 5% most extreme regions in all three tests designed for detecting positive selection (intersection between CLR, XP-CLR, and XP-EHH). Defined as outlier approach, reporting extreme values has been used in previous scans for detecting selection in humans ([@evz131-B83]; [@evz131-B68]; [@evz131-B29]), despite no additional tests have been implemented in [@evz131-B83], [@evz131-B29], or here to identify if the most extreme values we report can indeed be considered as outliers with respect to a parametric distribution. Our rationale behind this is that scores found in the upper tail of the distribution are expected to indicate deviations from neutrality and suggests regions/genes that may have undergone positive selection.

GRF Overrepresentation
----------------------

We evaluated if GRFs are enriched among the top 5% of all human protein-coding genes for each one of the three statistical tests for detecting positive selection (CLR, XP-CLR, and XP-EHH), and genetic differentiation (*F*~ST~) in any of three human populations (CEU, CHB, and YRI). To do this, we used our catalog of GRFs and generated two sets of genes, GRF and non-GRF genes. We then performed a Fisher's exact test to evaluate if GRF genes presented more extreme rank scores than other (non-GRFs) human genes. We then corrected the empirical *P* value using Bonferroni correction for multiple testing.

Regions with Biased Patterns of Variation and Long EHH within KRAB-ZNF Gene Clusters
------------------------------------------------------------------------------------

Using the annotation for KRAB-ZNF gene clusters described in [@evz131-B30], we first searched for regions with high CLR, XP-CLR, and XP-EHH (ranked scores \>1.3, empirical *P* of 0.05). For regions that exhibited long EHH results, we then tested whether the extension of uninterrupted single nucleotide polymorphisms (SNPs) with high XP-EHH rank scores was more than what could be expected by chance. We measured where the linkage disequilibrium decay falls below *r*^2^ = 0.1 in the empirical data (YRI ∼ 20 kb, CEU, and CHB ∼ 30 kb). We then performed 1,000 random samplings, of genomic regions of the same size as the KRAB-ZNF regions that display EHH larger (\>50 kb) and counted the number of uninterrupted SNPs with significant XP-EHH rank scores. We then implemented Bonferroni correction for multiple testing. By using a similar strategy, we additionally tested if the recombination rates observed for those 32 KRAB-ZNF clusters we detected as initial candidates were smaller than expected by chance. We randomly sampled genomic regions of the same size 1,000 times, calculated the mean of the recombination rates, and measured how often these were smaller than the mean observed in those KRAB-ZNF regions. We corrected for multiple testing (Bonferroni method). Afterward, we defined candidate regions for positive selection between the start and end positions of genomic regions with one or more haplotypes at high frequency, reduced variability and EHH larger than 50 kb.

To identify if the patterns of variation we observed in the 32 candidate KRAB-ZNF clusters resemble scenarios of selective sweeps and to evaluate whether the observed scores calculated from the empirical data are unusually high when compared with expectations under neutrality, we simulated data using Cosi2 simulator ([@evz131-B75]). Cosi2 simulator already considers a demographic model that is consistent for demography for these three human populations (Schaffner et al. 2005). We additionally adjusted this best fitted model following the adjustments implemented by [@evz131-B69], which tuned the model to generate sequence data that resemble the linkage disequilibrium decay, genetic variation and site frequency spectrum. We then performed 1,000 simulations for each of the 32 KRAB-ZNF clusters that exhibited multiple haplotypes at high frequency. We also performed singleton thinning following the values obtained by [@evz131-B69] to reduce the bias against rare variants due to the low coverage of the data (48% of the global singletons were removed). We finally compared the empirical data from these 32 candidate regions versus the simulated variation generated under neutrality.

Results
=======

A Comprehensive Catalog of Human GRFs for Studying Regulatory Evolution
-----------------------------------------------------------------------

To investigate the roles of GRFs during human evolution, we assembled the most up-to-date catalog of GRF genes combining the information from eight studies ([table 1](#evz131-T1){ref-type="table"} and [supplementary Methods](#sup1){ref-type="supplementary-material"}.pdf, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). In total, our catalog encompasses 3,344 genes ([supplementary table S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

###### 

Composition of 3,344 GRF Genes Considered in This Study (see [Supplementary Material, Supplementary Material](#sup1){ref-type="supplementary-material"} Online, for Selection Criteria) and the Sources Where These Genes Were Previously Cataloged

  Extant Inventories Human GRFs   Genes Included    \% Included
  ------------------------------- ---------------- -------------
  [@evz131-B51]                   1,640                84.1
  [@evz131-B81]                   1,804                96.6
  [@evz131-B70]                   1,734                87.2
  [@evz131-B59]                   572                  96.5
  [@evz131-B14]                   339                  96.3
  [@evz131-B78]                   2,998                92.3
  [@evz131-B301]                  2,225                86.6
  [@evz131-B91]                   1,506                99.8
  Present work                    3,344                 100

Following the detailed and curated classification of DNA-binding TF genes ([@evz131-B91]), we functionally grouped 1,509 GRF genes into 40 TF classes. ZNF genes are by far the most abundant class (807 genes) that further breaks down into ten subclasses, of which the KRAB-ZNF (410 genes) and non-KRAB C2H2 (280 genes) are the most abundant. They are followed by the classes of Homebox Domain (229 genes) and basic Helix-Loop-Helix (bHLH, 107 genes) ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

GRF Genes Are Overrepresented in Candidate Regions for Positive Selection
-------------------------------------------------------------------------

To identify GRFs located in genomic regions potentially subjected to positive selection, we analyzed the genome-wide rank scores for four different methods: the multiple-locus composite likelihood ratio (CLR) ([@evz131-B54]), cross-population CLR (XP-CLR) ([@evz131-B11]), cross-population extended haplotype homozygosity (XP-EHH) ([@evz131-B72]), and *F*~ST~ ([@evz131-B87]), in three human populations (CEU, CHB, and YRI). Regions obtaining the highest scores with these methods display patterns of variation consistent with genetic differentiation across populations and putative positive selection. GRFs are enriched among the top 5% of the ranked scores with the window based methods CLR and XP-CLR for most populations and pairwise comparisons (Fisher's exact test, Bonferroni corrected *P* \< 0.01) ([table 2](#evz131-T2){ref-type="table"}). With the XP-EHH test we found either depletion or no difference in ranked score distribution between GRFs and other genes when comparing CEU and CHB versus YRI. It is possible that the lower number of haplotype blocks that is characteristic of sub-Saharan populations ([@evz131-B24]; [@evz131-B31]) may have caused this observed depletion. Importantly, there was no significant difference between the distributions of the recombination rates between GRF and non-GRF genes (Kolmogorov--Smirnov test; *D* = 0.019; *P* = 0.18) and only a very small, albeit significant, correlation between gene length and the rank score (Spearman rank correlation, *P* \< 2.2e-16, *ρ* = 0.009) at population level ([supplementary Methods](#sup1){ref-type="supplementary-material"}.pdf, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). This indicates that differences in recombination rates and gene length probably did not bias our findings.

###### 

Association between GRF and non-GRF genes and the level of significance for three statistics for identifying candidate regions for positive selection and Measuring genetic differentiation (F~*ST*~).

  Test             Populations      Fisher Exact Test (Bonferroni Corrected *P*)   Odds Ratio      Feature
  ---------------- ---------------- ---------------------------------------------- --------------- ---------------
  CLR              CEU              3.96E-15                                       1.207           Enrichment
  CHB              9.72E-02         1.066                                          No difference   
  YRI              2.70E-07         1.132                                          Enrichment      
  XP-CLR           CEU versus CHB   3.96E-04                                       1.145           Enrichment
  CEU versus YRI   1.58E-14         1.278                                          Enrichment      
  CHB versus CEU   3.42E-10         1.235                                          Enrichment      
  CHB versus YRI   8.64E-08         1.203                                          Enrichment      
  YRI versus CEU   4.50E-09         1.219                                          Enrichment      
  YRI versus CHB   1                1.01                                           No difference   
  XP-EHH           CEU versus CHB   3.96E-15                                       1.367           Enrichment
  CEU versus YRI   3.96E-15         0.906                                          Depletion       
  CHB versus CEU   1.73E-03         1.043                                          No difference   
  CHB versus YRI   3.96E-15         0.896                                          Depletion       
  YRI versus CEU   1                1.016                                          No difference   
  YRI versus CHB   1                0.988                                          No difference   
  *F* ~ST~         CEU versus CHB   1.04E-01                                       0.971           No difference
  YRI versus CEU   1.19E-01         1.023                                          No difference   
  YRI versus CHB   1                1.013                                          No difference   

We next selected as candidates for positive selection, per each population, GRF genes which are found among the top 5% of the genome-wide rank score distribution in all three selection-detection methods (CLR, XP-CLR, and XP-EHH). This yielded 902 GRF genes for CEU, 759 GRF genes for CHB, and 1,697 GRF genes for YRI ([supplementary table S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Subsequently, we intersected the lists across populations and found that 306 GRF genes are found as candidates in all three populations ([supplementary fig. S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Although YRI has most population-specific candidates (892 GRFs, 53%), CEU and CHB display a bigger overlap among pairs of comparisons (between 74% and 76% of the total candidates, respectively).

We next evaluated, whether any of the 40 GRF classes was enriched among the top 5% of candidates with highest rank scores. Although the enriched classes (Fisher's exact test, Bonferroni corrected *P* \< 0.05) differed slightly depending on the method and population ([fig. 1](#evz131-F1){ref-type="fig"} and [supplementary table S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), five of the ten largest GRF classes were repeatedly found to be overrepresented: KRAB-ZNFs, non-C2H2, Homeo domain, High-mobility HMG, and Forkhead box TFs ([fig. 1](#evz131-F1){ref-type="fig"}).

![---Enrichment analyses for genes from the ten largest DNA--binding GRFs classes located in regions exhibiting high scores for four methods for detecting candidate regions for positive selection and one for measuring genetic differentiation. This heatmap shows the results from the Fisher's exact test after correcting for multiple testing by using the Bonferroni correction for each population or cross-population comparison, respectively.](evz131f1){#evz131-F1}

In total, these five GRF classes contain 180 candidates for positive selection. One hundred and twenty-one of these genes belong to the TF class C2H2 (68 non-KRAB C2H2 and 53 KRAB-ZNF candidates). They are followed by Homeo domain with 31, Fork head/winged helix with 19, and High-mobility-HMG domain with nine candidates ([supplementary table S4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Even though larger classes had more genes located within the top 5% of the highest scores, percentagewise they are also overrepresented: non-KRAB C2H2 (24%), KRAB-ZNF (13%), Homeo domain (13%), Forkhead box (28%), and High-mobility HMG (21%). Out of these 180 GRF, only 21 genes (12%) have also been listed in previous scans for selection ([@evz131-B72]; [@evz131-B64]; [@evz131-B52]; [@evz131-B302]; [@evz131-B29]), six of them being non-KRAB C2H2 (*ZFAT*, *ZBTB41*, *ZNF827*, *IKZF2*, *ZNF438*, and *ZBTB20*) and four KRAB-ZNF (*ZNF546*, *ZNF780A*, *ZNF780B*, and *ZNF492*) genes ([supplementary table S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). As a group, these five GRF classes are of relevance for processes like embryogenesis, development, chromatin modification, DNA replication and repair, among others ([table 3](#evz131-T3){ref-type="table"}).

###### 

Main Biological Roles of the Five Repeatedly Enriched GRF Classes within the Top 5% of Putative Regions for Positively Selection

  GRF Family          Examples of Main Regulatory Roles
  ------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Forkhead boxes      Cell growth, proliferation, differentiation, and longevity; embryonic development; cell migration; organ development, T-lymphocyte proliferation ([@evz131-B33]; [@evz131-B79], [@evz131-B80]).
  C2H2                Establishment of the chromosomal architecture; embryonic development, cell differentiation and proliferation, regulation of the cell cycle and apoptosis ([@evz131-B20]).
  KRAB-ZNF            Recruitment of TRIM28/KAP-1 for repression of gene expression, epigenetic silencing; early embryonic development; repression of ERVs and transposable elements; establishment of postzygotic reproductive isolation (speciation) ([@evz131-B57]; [@evz131-B93]; [@evz131-B35]; [@evz131-B20]). Function of most of them is unknown yet.
  Homeo domain        Body plan specification during embryogenesis, regulation of axial patterning, segment or cell identity and proliferation; formation and cell fate determination in metazoan development, crucial for normal temporospatial limb and organ development ([@evz131-B7]).
  High-mobility HMG   Bind temporally to nucleosomes to modify local chromatin architecture; DNA replication and repair; architectural proteins of nucleus and mitochondrial DNA; signaling regulators in the cytoplasm and as inflammatory cytokines ([@evz131-B84]; [@evz131-B42]; [@evz131-B49]).

High Nonsynonymous Genetic Differentiation within KRAB-ZNF Gene Clusters between Populations
--------------------------------------------------------------------------------------------

Out of all DNA-binding TF classes, KRAB-ZNF genes carry the highest number of highly genetically differentiated nonsynonymous SNPs affecting sequences in protein domains (*F*~ST~ \> 0.15) ([supplementary Methods](#sup1){ref-type="supplementary-material"}.pdf, [supplementary fig. S3](#sup1){ref-type="supplementary-material"}, and [supplementary table S6](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). A main characteristic of the KRAB-ZNF class is that most of its members are colocated in genomic regions (gene clusters) that span more than 150 kb ([@evz131-B30]). We thus analyzed all major KRAB-ZNF gene clusters for putative adaptive variation, where only polymorphic sites in CEU, CHB, and YRI populations with minor allele frequency \>0.001 were considered. We then manually explored where in the proteins putatively selected nonsynonymous changes are located to deduce possible functional effects.

Changes in the cysteine and histidine residues involved in forming the fingerlike structure for DNA-binding of C2H2 and KRAB-ZNF proteins, in the positions −1, 2, 3, and 6 that directly interact with specific nucleotides, or in the linkers determining the space between fingers, are expected to alter the DNA-binding specificity of ZNF proteins ([@evz131-B71]; [@evz131-B38]; [@evz131-B94]). We found 42 nonsynonymous SNPs with high to very high genetic differentiation (*F*~ST~ \> 0.15 \< 0.95) within 11 KRAB-ZNF clusters in chromosomes 1, 3, 9, 12, 16, 18, and 19. Thirty-two of these 42 SNPs are in C2H2 genes (16 KRAB-ZNF and one non-KRAB-ZNF genes) ([supplementary table S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Within this set of 42 nonsynonymous SNPs, 11 SNPs alter amino acid residues of ZNFs for eight KRAB-ZNF genes (*ZNF695*, *ZKSCAN7*, *ZNF502*, *ZNF571*, *ZNF132*, *ZNF10*, *ZNF90*, and *ZNF568*), whereas seven other SNPs affect amino acids of the linkers between ZNFs for four KRAB-ZNFs (*ZNF668*, *ZNF646*, *ZNF844*, and *ZNF492*), and five SNPs change the KRAB domains of three proteins (*ZNF695*, *ZKSCAN7*, and *ZNF48*) ([supplementary table S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). One highly differentiated nonsynonymous SNP modifies the amino acid residue of one of the two zinc-coordinating cysteines. Because these two cysteines (C2) together with two histidines (H2) tetrahedrally coordinate a zinc ion, which is essential for maintaining the stability and globular structure of the ZNFs ([@evz131-B19]; [@evz131-B94]), this modification very likely disrupts the DNA-binding capacity of the seventh ZNF motif of ZNF492. We additionally identified seven SNPs that affect the amino acid sequence of seven C2H2 proteins outside the above mentioned functional domains (*ZNF695*, *ZNF445*, *ZNF35*, *ZNF501*, *ZNF768*, *ZNF510*, and *ZNF568*). In addition to nonsynonymous SNPs affecting KRAB-ZNF genes, nine further highly differentiated nonsynonymous SNPs occur in seven other genes located within the KRAB-ZNF clusters, of which one, *KAT8*, is a GRF ([supplementary table S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Taken together, some non-KRAB C2H2 and KRAB-ZNF genes carry more than one highly differentiated nonsynonymous SNP modifying the sequence of the proteins. Based on the locations of these nonsynonymous SNPs, we suggest that they influence the interaction of these ZNF proteins with DNA (changes in the fingers), RNA, or with KAP1, a cofactor that interacts with the KRAB domain promoting the repressor activity of KRAB-ZNF proteins.

KRAB-ZNF Gene Clusters Contain Multiple Loci as Candidate Targets of Selection in CEU and CHB
---------------------------------------------------------------------------------------------

Positive selection alters the allele frequencies of SNPs in the neighborhood of the selected allele, thus creating a measurable biased pattern of genetic variation. Our results suggest that at least 32 out of 85 KRAB-ZNF gene clusters of the human genome carry genes with patterns of variation consistent with positive selection in at least one of the three populations studied here ([supplementary table S8](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). To asses if the patterns of variation we found resemble scenarios of selective sweeps, and to evaluate whether the observed scores calculated from the empirical data are unusually high when compared with expectations under neutrality, we performed coalescent simulations using a fine-tuned (best-fit) model for human demography generated for these three human populations ([@evz131-B74]) and adjusting it according to [@evz131-B69] (see Methods).

Our results suggest that 15 out of the 32 KRAB-ZNF clusters mentioned above harbor at least 27 regions with patterns of variation that are unlikely to be expected under neutrality (*P* \< 0.01) ([table 4](#evz131-T4){ref-type="table"}). Nineteen of these regions show rank scores that are among the top 1% of the whole genomic distribution. Using the H12 test ([@evz131-B25]) ([supplementary Methods](#sup1){ref-type="supplementary-material"}.pdf, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), we also found that 24 of these 27 regions exhibit one or more high frequency haplotypes with EHH (from 50 kb up to 385 kb). The patterns of genetic variation in these 27 regions may have resulted from positive selection ([fig. 2](#evz131-F2){ref-type="fig"}, supplementary figs. S4--S6, [Supplementary Material](#sup1){ref-type="supplementary-material"} online, [table 4](#evz131-T4){ref-type="table"}, and [supplementary table S9](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

###### 

KRAB-ZNF Clusters Exhibiting One to Multiple Regions Candidate for Positive Selection in Three Human Populations (CEU, CHB, and YRI)

  Chromosome     Start       End     Length Haplotype    Population  GRF Genes                                                                                                                 Non-GRF Genes                                                                                                                                                                                                                        *P*
  ------------ ---------- ---------- ------------------ ------------ ------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------
  chr19         9746367    9886927   0.14                   CEU      *ZNF562, ZNF812, ZNF846*                                                                                                                                                                                                                                                                                                                                       0.001
  chr19         9679258    9871747   0.19                   CHB      *ZNF561, ZNF812, ZNF121, ZNF562, ZNF846*                                                                                                                                                                                                                                                                                                                       0.001
  chr19         9623427    9710798   0.09                   CEU      *ZNF121, ZNF426*                                                                                                          *OR7D2*                                                                                                                                                                                                                              0.001
  chr19         9433260    9579560   0.15                   CHB      *ZNF177, ZNF266, ZNF560, ZNF559, ZNF559-ZNF177*                                                                                                                                                                                                                                                                                                                0.039
  chr7          99049790   99226981  0.18                   CEU      *CPSF4, ZKSCAN5, ZNF394, ZNF655, ZNF789, ZSCAN25*                                                                         *ATP5J2, FAM200A, LOC100289187, TRNA_Trp, ATP5J2-PTCD1*                                                                                                                                                                              0.001
  chr19         12290691   12477728  0.19                   CEU      *ZNF442, ZNF44, ZNF563, ZNF136*                                                                                           *AK023304, AX721123*                                                                                                                                                                                                                 0.001
  chr19         11569316   11654956  0.09                   CEU      *ZNF653*                                                                                                                  *ECSIT, ELAVL3, CNN1*                                                                                                                                                                                                                0.001
  chr19         11569316   11651077  0.08                   CHB      *ZNF653*                                                                                                                  *ECSIT, ELAVL3, CNN1*                                                                                                                                                                                                                0.001
  chr19         11681367   11763981  0.08                   CHB      *ZNF627, ZNF833P*                                                                                                         *ACP5*                                                                                                                                                                                                                               0.001
  chr19         11911546   12194995  0.28                   CHB      *ZNF433, ZNF439, ZNF440, ZNF69, ZNF700, ZNF763, ZNF844, ZNF878, ZNF491*                                                   *AX747405*                                                                                                                                                                                                                           0.001
  chr19         19518253   19658472  0.14                   CEU      *NDUFA13, GATAD2A*                                                                                                        *CILP2, TSSK6, YJEFN3*                                                                                                                                                                                                               0.041
  chr19         20219280   20473261  0.25                   CEU      *ZNF90, ZNF486, ZNF826P*                                                                                                                                                                                                                                                                                                                                       0.001
  chr19         22736627   22847686  0.11                   CEU      *ZNF492*                                                                                                                  *LOC440518 (GOLGA2P9), AC011516.2*                                                                                                                                                                                                   0.001
  chr19         22849806   23075779  0.23                   CEU      *ZNF492, ZNF723+NP, ZNF99*                                                                                                                                                                                                                                                                                                                                     0.001
  chr19         22736073   22789623  0.05                   CHB                                                                                                                                *LOC440518 (GOLGA2P9)*                                                                                                                                                                                                               0.032
  chr19         22797143   23066423  0.27                   CHB      *ZNF492, ZNF723+NP, ZNF99*                                                                                                *AC011516.2*                                                                                                                                                                                                                         0.008
  chr19         23167970   23274391  0.11                   CEU      *ZNF728*                                                                                                                                                                                                                                                                                                                                                       0.001
  chr19         23566484   23647327  0.08                   CEU      *ZNF91*                                                                                                                   *LINC01224*                                                                                                                                                                                                                          0.014
  chr19         24159713   24258543  0.1                    CEU      *ZNF254*                                                                                                                  *AK092080, AK092150*                                                                                                                                                                                                                 0.001
  chr19         24165702   24249831  0.08                   CHB      *ZNF254*                                                                                                                  *AK092080, AK092150*                                                                                                                                                                                                                 0.001
  chr19         20912174   21159445  0.25                   CHB      *ZNF85, ZNF66*                                                                                                                                                                                                                                                                                                                                                 0.009
  chr19         20961835   21046198  0.08                   YRI      *ZNF66*                                                                                                                                                                                                                                                                                                                                                        0.009
  chr19         35379737   35443530  0.06                   CHB      *ZNF30*                                                                                                                   *LINC00904, and 17 PiRNAs*                                                                                                                                                                                                           0.001
  chr19         37401178   37684941  0.28                   CHB      *ZNF829, ZNF585A, ZNF585B, ZNF345, ZNF568, ZNF420*                                                                                                                                                                                                                                                                                                             0.003
  chr19         38129568   38255337  0.13                   CHB      *ZNF781, ZNF607, ZFP30, ZNF573*                                                                                                                                                                                                                                                                                                                                0.039
  chr19         52350176   52471785  0.12                   CHB      *ZNF577, ZNF649, ZNF613, ZNF350*                                                                                          *TRNA_Lys*                                                                                                                                                                                                                           0.033
  chr19         52350054   52407858  0.06                   CEU      *ZNF577, ZNF649, ZNF613, ZNF350*                                                                                                                                                                                                                                                                                                                               0.005
  chr19         52409615   52511217  0.1                    CEU      *ZNF613, ZNF350, ZNF615*                                                                                                  *TRNA_Lys*                                                                                                                                                                                                                           0.025
  chr19         52533305   52665989  0.13                   CEU      *ZNF432, ZNF841, ZNF616, ZNF836*                                                                                                                                                                                                                                                                                                                               0.014
  chr19         52995729   53064163  0.07                   CEU      *ZNF578, ZNF808*                                                                                                                                                                                                                                                                                                                                               0.031
  chr3          40531136   40630291  0.1                    CEU      *ZNF619, ZNF620, ZNF621*                                                                                                                                                                                                                                                                                                                                       0.031
  chr6          28040581   28337801  0.3                    CEU      *ZSCAN12P1, ZSCAN16, ZNF187, ZNF192, ZNF192P1, ZNF389, ZNF193, ZKSCAN4, ZKSCAN3, ZNF165, ZNF323, PGBD1, NKAPL*            *TRNA_Ser, TOB2P1, piRNA(DQ581281)*                                                                                                                                                                                                  0.001
  chr6          28342884   28426378  0.08                   CEU      *ZSCAN12, ZSCAN23*                                                                                                                                                                                                                                                                                                                                             0.003
  chr12         1.33E+08   1.34E+08  0.3                    CHB      *ZNF891+N, ZNF605, ZNF26, ZNF84, ZNF140, ZNF10, ZNF268*                                                                                                                                                                                                                                                                                                        0.001
  chr1          2.47E+08   2.47E+08  0.1                             *ZNF124, ZNF669, ZNF670, ZNF670-ZNF695, ZNF695*                                                                           *C1orf229*                                                                                                                                                                                                                           0.001
  chr3          44554702   44742478  0.19                   CHB      *ZNF167, ZNF197, ZNF35, ZNF445, ZNF660, ZNF852*                                                                                                                                                                                                                                                                                                                0.001
  chr16         31009588   31165239  0.16                            *FBXL19, KAT8, SETD1A, SRCAP, TBC1D10B, ZNF48, ZNF629, ZNF646, ZNF668, ZNF688, ZNF689, ZNF747, ZNF764, ZNF768, ZNF771*7   *AK056973, BC039500, BC073928, BCKDK, BCL7C, C16orf93, CD2BP2, CTF1, DCTPP1, FBRS, HSD3B7, ITGAL, MIR4518, MIR4519, MIR762, MYLPF, ORAI3, PHKG2, PRR14, PRSS36, PRSS53, PRSS8, RNF40, SEPHS2, SEPT1, SNORA30, STX1B, STX4, VKORC1*   0.001

[Note]{.smallcaps}.---The patterns of variation are considered unlikely to be expected under neutrality based on the results from our simulated data. Regions found in two populations were kept separately. The significance was assessed by simulating a null model using coalescence (see Materials and Methods). An extended version of this table can be found in [*supplementary table S9*](https://academic.oup.com/gbe/article-lookup/doi/10.1093/gbe/evz131#supplementary-data), [*Supplementary Material*](https://academic.oup.com/gbe/article-lookup/doi/10.1093/gbe/evz131#supplementary-data) online.

![---KRAB-ZNF gene cluster located on the chromosome 6 of four European population (6: 28.04--28.42) exhibiting very high genetic differentiation (*a*), high CLR (*b*) and XP-CLR (*c*) scores, long EHH (*e*, *f*) and multiple high frequency haplotypes. Note that the scale on the *y* axis differs between plots. All values correspond to the raw scores obtained for each method. In the *F*~ST~ track (*a*), SNPs over the solid lines indicating moderate (*F*~ST~ \> 0.15, blue line) and high (*F*~ST~ \> 0.25, red line) genetic differentiation. Bigger dots indicate two highly differentiated SNPs, rs1635 (CEU vs. CHB, red) and rs1997660 (CEU vs. YRI, green). H12 track statistics (*e*) shows the H scores for: homozygosity of the most frequent haplotype (H1), homozygosity calculated using all, except the most frequent haplotype (H2), the ratio between H2/H1, and the combination of the most and second most frequent haplotypes (H12). In H12 track (*f*) for four populations with European, one with Asian and one with African background. The H12 threshold we defined genome wide (solid red line, 0.1). Dotted vertical line indicate extension of positively selected region within this KRAB-ZNF cluster.](evz131f2){#evz131-F2}

Using a curated comprehensive catalog of genes and variants associated with human diseases and the gene-disease associations from the MEDLINE database, both available in DisGeNET ([@evz131-B65]), we identified that out of the 27 regions with one or more haplotypes at high frequency, 17 carry GRF genes that have been associated with medical conditions such as muscle weakness, obesity, hyperparathyroidism, degenerative polyarthritis, heart diseases, azoospermia, cognitive disabilities, and multiple types of cancers, among others ([supplementary table S9](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Acknowledging that the biological, molecular and functional characterization, apart from their putative gene regulatory function, of most GRFs and especially of KRAB-ZNF proteins, is still incipient, we present and discuss here three regions for which functions and medical relevance has been described during the last two decades. We further discuss their putative regulatory roles in the evolution and adaptation of human-specific traits. Extended information for other regions can be found in the [supplementary table S10](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online, and in the supplementary figs. S4--S6, [Supplementary Material](#sup1){ref-type="supplementary-material"} online.

Selective Sweep on a KRAB-ZNF Gene Cluster in CEU Is Associated with Schizophrenia in CHB
-----------------------------------------------------------------------------------------

A KRAB-ZNF cluster located on the chromosome 6 (28.04--28.42) displays multiple regions with high CLR, XP-CLR, and XP-EHH scores in CEU. It also contains variants that suggest very high genetic differentiation (*F*~ST~) between CEU compared with CHB and YRI ([fig. 2](#evz131-F2){ref-type="fig"}). In addition, more than 100 SNPs exhibit very high *F*~ST~ (\>0.15 \< 0.52) when comparing CEU with the other two populations ([fig. 2](#evz131-F2){ref-type="fig"}, *F*~ST~ track). We also detected that the level of genetic differentiation in this region was unusually high when compared with regions evolving under neutrality scenarios (simulated data, *P* \< 0.001, [supplementary fig. S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Genetic variation within this KRAB-ZNF gene cluster has been associated with at least three medical conditions in humans: hemochromatosis (iron overload, the most prevalent genetic condition in Europeans), CD4:CD8 lymphocyte ratios, low production of CD8+ effector memory (T~EM~) and double negative (T~DN~) T-cells, and schizophrenia.

This KRAB-ZNF cluster is composed of at least 16 genomic elements: 11 GRF genes (*ZSCAN16*, *ZNF187*, *ZNF192*, *ZNF389*, *ZNF193*, *ZKSCAN4*, *ZKSCAN3*, *ZNF165*, *ZNF323*, *PGBD1*, and *NKAPL*), three pseudogenes (*ZSCAN12P1*, *ZNF192P1*, and *TOB2P1*), one tRNA-Ser and one piRNA-DQ581281. Out of the 100 highly differentiated SNPs, only three correspond to nonsynonymous SNPs in coding regions of two genes, namely in the first exon of *NKAPL* (rs12000 and rs1635) and in the seventh exon of *PGBD1* (rs1997660) ([fig. 2](#evz131-F2){ref-type="fig"}, *F*~ST~ track, [supplementary table S10](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Interestingly, the rs1635 genotype is almost fixed in CEU with about 95% of the individuals carrying the variant *C\|C*. In contrast, this genotype is found in only about 50% of the individuals from CHB and YRI. In these populations, the heterozygous state *A\|C* is frequent with 40% and 45%, respectively ([fig. 3](#evz131-F3){ref-type="fig"}). Allelic variants in rs1635 and rs12000 have been associated with schizophrenia in Han Chinese ([@evz131-B12]; [@evz131-B86]). Conversely to rs1635, the genotype *G\|G* for SNP rs1997660 (*PGBD1* gene) is found in almost all individuals from YRI (95%), whereas it is at lower frequency in CHB (36%) and at very low frequency in CEU (0.8%) ([fig. 3](#evz131-F3){ref-type="fig"}). Considering the clear differences in genotype frequencies for rs1635 and rs1997660 between populations, we suggest that these two SNPs are involved in local adaptation.

![---Three missense variants located in two genes within a KRAB-ZNF gene cluster that might have undergone positive selection in European populations. Top left and middle, allelic frequencies of two nonsynonymous SNPs located in *NKAPL* gene. Top right, allelic frequencies of one nonsynonymous SNP located in *PGDB1* gene. Bottom, genotypic frequencies for CEU, CHB, and YRI.](evz131f3){#evz131-F3}

Further exploration suggests that genes within this KRAB-ZNF cluster might have experienced a recent selective sweep in CEU and in four other European populations: Finnish in Finland, Toscani in Italia, and British in England and Scotland ([fig. 2](#evz131-F2){ref-type="fig"}, H12 track). By using H12 statistics, we were able to detect that this KRAB-ZNF cluster contains two regions with one predominant haplotype with long EHH about five kb apart from each other that together span about 400 kb in CEU ([fig. 2](#evz131-F2){ref-type="fig"} and [supplementary fig. S3](#sup1){ref-type="supplementary-material"}*h* and *i*, [supplementary table S10](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The length of the EHH for these European populations ranges from 300 kb in Italian to 490 kb in Finnish ([supplementary fig. S8](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), suggesting that it is very likely that the extension, strength and time of this selective event differs across European populations.

Positive Selection on a Human-Specific KRAB-ZNF Cluster Involved in Eye Development
-----------------------------------------------------------------------------------

Two closely located regions on chromosome 19, 7 kb apart from each other, encompassing together around 340 kb (chr19: 22.7--23.04), carry very high genetic differentiation (*F*~ST~) and long EHH in CEU and CHB populations. When compared with YRI population, these regions also showed high CLR and XP-EHH scores, which suggests a selective sweep ([supplementary fig. S9](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). By analyzing the ratio from the H2/H1statistics, which tends to increase as the sweep becomes softer ([@evz131-B25]), we suggest that CEU may have experienced a harder sweep than CHB population ([supplementary fig. S4](#sup1){ref-type="supplementary-material"}*A*, *d* and *e* and [supplementary fig. S9](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Indeed, it is possible to observe two well defined haplotypes that are at high frequency for CHB ([supplementary fig. S4](#sup1){ref-type="supplementary-material"}*B*, *e* and *f*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). One gene within this region, the human-specific gene *ZNF492* ([@evz131-B58]), was recently reported as a positively selected gene in nine individuals with European background ([@evz131-B29]).

ZNF492 regulates the expression of the retinal pigment epithelium (RPE) specific protein (RPE65) ([@evz131-B46]). We found that both genes, *ZNF492* and *RPE65*, display higher average expression in the human retina compared with most other tissues. *ZNF492* is more highly expressed in the RPE during development than during adulthood ([supplementary fig. S10](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), suggesting that it might play an important role during RPE development. Three nonsynonymous SNPs can be found within *ZNF492*. Two missense SNPs (rs138844698 and rs141989264) concern amino acid changes that are fully conserved in CEU and CHB (100%), but not in YRI (66%). These two variants alter the amino acid configuration of the linker between the first and second ZNFs of *ZNF492*, which is expected to alter the cap configuration of the C terminus (C-cap) of the first finger, tweak its DNA-binding affinity ([@evz131-B38]; [@evz131-B94]), and potentially affect its regulatory properties. The third SNP (rs144581197) changes a highly conserved cysteine residue (TGT) with essential role in the proper folding of the seventh ZNF of ZNF492 to a tyrosine (TAT) ([supplementary fig. S11](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Although the *A* allele for rs144581197 is relatively frequent in YRI (∼56%) and other African populations (between 39% and 57%, of the African populations from the 1000 genomes project), it is found in \<1% of individuals from CEU and CHB ([supplementary fig. S11](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The *A* allele is also present in individuals from populations located in regions with moderate to high solar UV index ([@evz131-B89]): Puerto Ricans, 8%; Colombians, 7%; Iberian Spaniards, 4%; Peruvians, 3.5%; Mexicans, 2%; Tuscans, 2%, which is intriguing for a gene expressed in the RPE and other eye tissues.

This KRAB-ZNF region resulted from multiple intrachromosomal segmental duplications ([@evz131-B6]) that gave origin to *ZNF492*. Although the sequence similarity of the entire region is about 98--99% between modern and archaic humans (Denisovan and Neandertal, respectively), it is only about 89% between human and chimpanzee. Therefore, it is likely that the duplication events and the rearrangements of this region occurred during the evolution of the homo species. We additionally explored the three nonsynonymous SNPs of *ZNF492* in Denisovan and Neanderthal. We conclude that individuals from archaic humans carry the variants fixed in CEU, CHB. This suggests that the alternative variants we observed for these SNPs, especially rs144581197, might have resulted from de novo mutations in YRI, and other African populations.

Recent Incomplete Selective Sweep on a KRAB-ZNF Gene Cluster on Chromosome 3 Might Contribute to the Male Fertility
-------------------------------------------------------------------------------------------------------------------

One KRAB-ZNF cluster located on chromosome 3 (44.55--44.74) exhibits long EHH, high scores for CLR and XP-CLR, and high genetic differentiation between CHB and the other two populations ([fig. 4](#evz131-F4){ref-type="fig"}). The EHH spans about 272 kb in a region that contains three KRAB-ZNF genes (*ZNF167*, *ZNF197*, and *ZNF445*) and three C2H2 (*ZNF35*, *ZNF660*, and *ZNF852*). The hierarchical boosting data for classifying hard sweeps in human populations ([@evz131-B69]) indicated that this KRAB-ZNF cluster might have experienced an incomplete and recent selective sweep in CHB ([fig. 4](#evz131-F4){ref-type="fig"}).

![---KRAB-ZNF gene cluster exhibiting hard sweep on the chromosome 3 from CHB population (3: 44.55--44.74). Three methods for detecting positive selection and *F*~ST~ for measuring genetic differentiation produced very high scores for this region (*a*--*d*) when compared with other regions genome wide. Note that the scale on the *y* axis differs between plots. All values correspond to the raw scores obtained for each method. *F*~ST~ (*b*) and XP-EHH (*d*) results indicate very high genetic differentiation and a haplotype with EHH that spans about 188 kb (vertical dotted lines). This KRAB-ZNF cluster contains eight ZNF genes. The regions flanking up and downstream of this 188-kb haplotype also exhibit EHH, which suggests that they correspond to the same selective sweep (about 272 kb). Four highly differentiated nonsynonymous SNPs (green: CHB vs. YRI; red: CEU vs. YRI) in regions coding for protein domains of *ZKSCAN7*, *ZNF35*, *ZNF501*, and *ZNF502* may be of functional relevance. Hierarchical boosting results (*e*) suggest this correspond to an incomplete recent selective sweep. Solid and dotted horizontal lines indicate thresholds for *F*~ST~ (blue: *F*~ST~ \> 0.15, red: *F*~ST~ \>0.25) and boosting significance thresholds as defined by [@evz131-B69] (red: complete, orange: incomplete, blue: recent, and purple: ancient), respectively.](evz131f4){#evz131-F4}

Further exploration revealed six nonsynonymous SNPs with high genetic differentiation across populations. The SNP rs2272044, located in the second exon of the gene *ZNF35*, exhibit great genetic differentiation (*F*~ST~ \> 0.56 \< 0.8) ([fig. 4](#evz131-F4){ref-type="fig"}). Although about 98% of the individuals from CHB carry the allele G, this is only present in 30% of the individuals from CEU, and absent in YRI (100%). Despite the understanding of functional roles of *ZNF35* gene in humans is still scarce, its highly conserved homolog in mice suggests that it might play important roles in male fertility ([@evz131-B67]) by regulating pathways involved in the release of differentiated spermatogenic cells into the central lumen of the seminiferous tubule in testis from adults ([@evz131-B101]). The deletion of *ZNF35* causes the premature release of undifferentiated pachytene spermatocytes into the lumen in subfertile individuals ([@evz131-B101]). Certainly, *ZNF35* is highly expressed in pachytene spermatocytes and round spermatids ([@evz131-B67]; [@evz131-B101]), as well as in testis ([@evz131-B26]), and its protein has been found in spermatogenic cells ([@evz131-B101]).

Two other nonsynonymous SNPs located in the gene *ZKSCAN7* (rs13081859, rs9835485) also suggest very high genetic differentiation (*F*~ST~ \> 0.23) *F*~ST~ ([fig. 4](#evz131-F4){ref-type="fig"} and [supplementary table S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). These two SNPs affect the amino acid sequence of the KRAB domain and the first amino acid between the two histidines of the first ZNF of *ZKSCAN7*, respectively. Both variants may have functional implication in the interactions of ZKSCAN7 with the coregulator *KAP1* (*TRIM28*) and the DNA-binding sites.

Discussion
==========

We generated an up-to-date catalog for human GRFs, comprising 3,344 protein-coding genes, to investigate if these types of genes are frequently observed in regions with signatures of positive selection among human populations. Although about 53% of the GRFs located in candidate regions for selection for YRI seem to be population specific, the greater overlap detected between CEU and CHB suggests that genetic variation in the majority of the GRFs for CEU and CHB has resulted from evolutionary processes that followed the migration Out of Africa. At least five GRF classes are overrepresented in candidate regions for positive selection in three human populations (CEU, CHB, and YRI), pointing to an enormous potential for regulatory diversity between populations. We also detected that at least 15 KRAB-ZNF gene clusters harbor loci with high genetic differentiation between pairs of populations, considerable reduction in genetic variation within populations, and EHH that spans between 50 and 385 kb. Our results are unlikely to be confounded by demographic events, for instance, bottlenecks or population expansions, because we implemented several steps that are in agreement with recommended practices when identifying candidate regions for positive selection, among them our outlier approach, analyzing the site frequency spectrum, using haplotype based methods and coalescent simulations for neutrality ([@evz131-B95]). Our results strongly indicated that the genetic variation we characterized here may be responsible of subtle to rough regulatory changes of relevance for human adaptive regulatory diversity.

Positive Selection of C2H2 Genes as a Potential Source for Regulatory Diversity
-------------------------------------------------------------------------------

By far the highest incidences of genes within candidate regions for positive selection was found for KRAB-ZNF genes. This class has also experienced lineage-specific duplications and functional divergence in primates ([@evz131-B58], [@evz131-B57]; [@evz131-B53]) and has been implicated in speciation processes ([@evz131-B18]; [@evz131-B57]) and in the suppression of endogenous retrovirus (ERVs) ([@evz131-B77]; [@evz131-B32]; [@evz131-B47]; [@evz131-B73]). Therefore, it becomes interesting that genes from KRAB-ZNF class show very high levels of genetic differentiation at population-specific level in humans.

The ways in which KRAB-ZNF and other C2H2 proteins recognize and bind to DNA to control the expression of other genes have been documented in considerable detail ([@evz131-B94]), allowing it to draw conclusions about functional impacts of the genetic variation we observed for KRAB-ZNF genes. KRAB-ZNF proteins typically contain modular Cys2-His2-ZNF finger domains joined together in tandem arrays by linker regions ([@evz131-B30]). Changes in the cysteine or histidine residues involved in forming the fingerlike structure, in the positions −1, 2, 3, and 6 that are binding specifically to DNA, or in the linkers between the finger domains can alter the regulatory specificity of KRAB-ZNF proteins ([@evz131-B38]; [@evz131-B94]). Such changes can broadly affect the phenotype, for instance, a mutation in the linker between the 18th and 19th C2H2 finger domain of *ZNF407* (the c.C5054G/p.S1685W) causes cognitive impairment ([@evz131-B34]). We identified nonsynonymous SNPs in functionally relevant positions of ZNF proteins with very high genetic differentiation across human populations, even though most of this variation lays outside the sequences coding for protein domains of KRAB-ZNF. This is consistent with a previous study that suggested that nonsynonymous SNPs on protein domains and contacting residues of older KRAB-ZNF genes are prone to evolve under purifying selection, that is, are less frequent ([@evz131-B35]). The variants that can be predicted to change the functions of the KRAB-ZNF proteins should be followed up experimentally to reveal their functional consequences.

Variation in the tandem array of ZNF domains may result in diversifying mechanisms to downregulate the expression of newly evolved TEs in humans ([@evz131-B47]). In turn, changes in expression of TEs might lead to important phenotypic differences between human populations ([@evz131-B85]). For instance *ZNF35*, a gene that carries highly differentiated nonsynonymous SNPs between the human populations, and that is located in a region we identified as strong candidate for a hard selective sweep in CHB, can bind and regulate specific classes of EREs ([@evz131-B53]). Human-specific ERVs affect spermatogenesis and lead to male infertility ([@evz131-B66]), a global medical condition with lower prevalence in China and other Asian countries ([@evz131-B56]). *ZNF35* is involved in controlling normal spermatogenesis, and ultimately male infertility in human ([@evz131-B101]). [@evz131-B43] recently suggested that this region has convergently evolved in six Asian populations: Buryat, CHB, Amagasaki, Tibetan, Hui, and Han. Consequently, we suggest that this region, including the variants reported here for *ZNF35*, contributes to regulatory differences across human populations that could be of relevance for male fertility.

KRAB-ZNF Gene Clusters Have Experienced Selective Sweeps and Probably Contributed to Rapid Human Adaptation
-----------------------------------------------------------------------------------------------------------

Regions with EHH, reduced variability, low recombination rates, and high genetic differentiation across populations are indicative for positive selection ([@evz131-B72]; Vitti et al. 2013). We found that at least 27 regions (\>50 kb) within 32 KRAB-ZNF gene clusters exhibit unusually biased patterns of genetic variation when compared with expectations under neutrality, high differentiation between populations, reduced genetic variation within populations, and EHH. Twenty-four of these regions have one or more high frequency haplotypes with EHH, suggesting that selective sweeps in these KRAB-ZNF clusters may have taken place, especially in CHB and CEU populations. Three other KRAB-ZNF clusters, on chromosomes 1, 3, and 16 of CHB seem to have experienced harder selective sweeps. The composition of genes within these 27 regions emphasizes that multiple selective sweeps, with different strength and age, might have taken place in regions rich in KRAB-ZNF genes, probably conferring regulatory adaptive responses in human populations, for instance, CHB and CEU.

Human traits and capacities have evolved as result of local adaptation to different environmental pressures. Genes that control more than one trait, as GRFs do, may be prone to antagonistic pleiotropy, where at least the regulation of one trait has a positive effect on fitness, but also negatively impact on other traits ([@evz131-B90]; [@evz131-B13]). Thus, functional disease association of genes located within these 27 regions might reveal likely biological effects of the positively selected variation at population-specific level. For these regions, we found associations that might explain, for instance, differences in prevalence of phenotypical alterations such as in visual impairment, immunological response, mental disorders, body weight, and multiple types of cancer.

Selective Sweep Might Have Fine-Tuned the Regulation of CD8+ T Cell Response and Influence the Prevalence of Schizophrenia
--------------------------------------------------------------------------------------------------------------------------

An interesting KRAB-ZNF cluster on chromosome 6 shows signatures of a selective sweep in CEU and likely in at least four other European populations (Finnish, Italy, England, and Scotland). Previously documented genetic variation within this region has been associated with hemochromatosis, the most prevalent inherited disorder in people with northern European ancestry ([@evz131-B2]). Hemochromatosis patients from Portugal, US America, and Norway, carrying the most frequent haplotype produce significantly fewer mature CD8+ T-cells (T~EM~ and T~DN~ CD28^−^CD27^−^) when compared with patients carrying the less frequent haplotype ([@evz131-B48]; [@evz131-B15]). Genetic variation within this KRAB-ZNF has been also significantly associated with CD8 T-cell production in more than 2,500 individuals ([@evz131-B21]). One gene located in this region, *NKAPL*, is a transcriptional repressor acting on Notch target genes ([@evz131-B60]) and is essential for T-cell development and maturation ([@evz131-B62]). Loss-of-function of NKAPL results in a significant decrease of CD8+ single (T~SP~) and double positive (T~DP~) T-cells and in a significant disproportionate increase of CD8+ T~DN~ during T-cell development ([@evz131-B62]). We suggest that the genomic differentiation we detected between CEU and CHB and YRI has a measurable functional effect on the maturation and development of CD8+ T-cells, significantly changing the proportions of CD8+ cells, by mainly modulating the premature maturation of T~EM~ and T~DN~ types. We speculate that a positive selective event in the *NKAPL* gene has occurred in CEU and other European populations, whereas *NKAPL* probably evolved under balancing selection (overdominance) in CHB, YRI, and other human populations. As result, individuals carrying the most frequent haplotype found for *NKAPL* in CEU will produce much less T~EM~ and T~DN~ CD8+ T-cells, whereas individuals carrying other haplotypes will be affected by a dysregulation of the CD8 T-cell development through *NKAPL*.

The SNP rs1635 in *NKAPL* has further been associated with schizophrenia in patients from the Han Chinese and Jewish populations ([@evz131-B98]; [@evz131-B4]; [@evz131-B36]; [@evz131-B100]; [@evz131-B86]; [@evz131-B61]). Human immune response and altered T-cell immunity have been acknowledged to be associated with schizophrenia, although, the connection has not been fully depicted yet. Interestingly, T~EM~ and T~DN~ T-cells, which development and maturation is altered by *NKAPL* (see above), are specifically connected with the immune surveillance of the central nervous system in humans ([@evz131-B76]; [@evz131-B37]). We speculate that genetic variation in *NKAPL* gene causes a disbalance in CD8+ T~EM~ and T~DN~ production and might be one of the reasons for the higher prevalence of schizophrenia in populations with Asian background when compared with Europeans. Our conclusions support findings from [@evz131-B22], who depicted how evolutionary processes such as admixture and environmental stressors may have influenced particular genetic variants in Asian populations.

In addition, CD8+ T~EM~ and T~DN~ T-cells specially produce granzyme K in the human brain ([@evz131-B76]), a serine protease found in cytotoxic lymphocytes. It is possible that granzyme K promotes inflammation, cytokine production ([@evz131-B88]), and performs other functions that can alter the neurological processes in the brain. This scenario is in line with the results obtained by [@evz131-B97], who suggested that *NKAPL* rs1635 (T152N mutation) may be related to central nervous system development and significantly associated with the plasma levels of Intercellular adhesion molecule--1 (sICAM1), an important cell adhesion molecule with essential roles in inflammatory processes.

Taken together, we contemplate a scenario in which individuals carrying the less frequent variants for the SNP rs1635, or other SNPs that lead to gain-, switch-, or loss-of-function in NKAPL, may produce drastic changes in CD8+ T~EM~ and T~DN~ amounts, which might result in higher presence of these T-cells in their brains, and probably higher amounts of granzyme K. Although a full characterization of the impact of *NKAPL* diversity on the development of CD8+ T-cells and central nervous system functions has yet to be performed, our results provide a testable hypothesis for the molecular basis that might underlie differences in the prevalence and risk factors for schizophrenia between human populations.

Selective Sweep in CEU and CHB Might Be Associated with Regulatory Pathways of the Retinal Epithelium
-----------------------------------------------------------------------------------------------------

We identified a KRAB-ZNF cluster of about 340-kb EHH on chromosome 19 of CEU and CHB populations. The genomic architecture of this KRAB-ZNF cluster resulted from multiple intrachromosomal duplications ([@evz131-B5], [@evz131-B6]) that gave origin to the genes *ZNF492* and *ZNF99*. Based on the sequence similarity we found between AMHs, Neandertal and Denisovan, we suggest that this region evolved before AMHs and archaic humans split from their last common ancestor. This region likely underwent positive selection in at least two human populations, CEU and CHB. Similar results were found for *ZNF492* in nine unrelated individuals with European background ([@evz131-B29]).

RPE65, a highly tissue-specific protein ([@evz131-B46]), is essential in the visual cycle pathway that regenerates the chromophore 11-*cis*-retinal (rhodopsin). Rhodopsin protects the retina and choroid against light rays ([@evz131-B28]). *ZNF492* enhances the expression of *RPE65* ([@evz131-B9]; [@evz131-B46]), an essential protein for RPE development ([@evz131-B46]). *RPE65* is mostly expressed until late development of the retinal epithelium, 1--4 days after birth, and 2 days before the maturation of the photoreceptor cells ([@evz131-B46]). Both genes, *ZNF492* and *RPE65* seem to have very similar expression patterns in the human RPE and retina ([@evz131-B10]), although the fold-change ratios between *RPE65* and *ZNF492* of adult humans show very different patterns when compared with other retinal tissues and cell lines. Considering that ZNF492 coregulates and enhances the expression of *RPE65* gene in RPE cells in humans ([@evz131-B9]; [@evz131-B46]), we hypothesize that this KRAB-ZNF region might confer variation that influences the development of the human eye, for instance, the retinal epithelium. Supporting our hypothesis, genetic variants within this KRAB-ZNF cluster has been functionally associated with pathologies of the human eye in Caucasians ([@evz131-B41]).

We found three missense variants in *ZNF492* that are expected to alter the regulatory properties of ZNF492 in humans and thus, might alter the expression of *RPE65* and other target genes. The SNP (rs144581197) results in a change of a cysteine to a tryptophan residue (C314Y), rendering the seventh ZNF domain unfunctional in more than half of the individuals from YRI. Interestingly, also between 39% and 57% of the individuals from the seven other African populations ([@evz131-B1]) carry this mutation. Further, this variation can also be found in individuals from populations located in latitudes with moderate to high sun rays exposure ([@evz131-B89]), although with lower frequency than in the African populations. The other two SNPs (rs138844698 and rs141989264) modify the C-cap conformation of the linker between the first and second finger of ZNF492, thus likely tweaking its DNA-binding affinity ([@evz131-B38]; [@evz131-B94]) and regulatory functions. Given that these variants exist almost not at all in CHB and CEU, we suggest that population-specific variation of *ZNF492* may alter the development of RPE during early human stages, and posteriorly influence the regeneration of rhodopsin during adulthood and senescence in humans, presumably in adaptation to different exposure to sun rays. UV and visible radiation can damage the RPE and other structures in the eye causing different medical conditions; for instance, macular degeneration, which has a higher prevalence in Caucasian populations ([@evz131-B55]; [@evz131-B50]; [@evz131-B16]).

Conclusions
===========

Using the most recent catalog for GRFs, the information from the 1000 genomes project, and data obtained by multiple methods for detecting positive selection in humans, we identified GRF genes located in genomic regions that may have undergone positive selection in at least one of three human populations. Our results present several scenarios where five of the largest classes of GRFs may have contributed to adaptive regulatory changes within human populations. Further inspection of nonsynonymous variants suggests how genetic variation, mainly in non-KRAB C2H2 and KRAB-ZNF ZNF classes, could confer regulatory diversity in humans, thus possibly contributing to the evolution of particular traits. Because KRAB-ZNF proteins control the expression of many genes, it is very likely that KRAB-ZNF genes located within target regions for positive selection are prone to antagonistic pleiotropy. We found that many KRAB-ZNF gene clusters targeted by natural selection have been connected with multiple medical conditions of relevance for human health, for instance, muscle weakness, obesity, hyperparathyroidism, degenerative polyarthritis, heart diseases, azoospermia, cognitive disabilities, and multiple types of cancers, among others. Our work identified several interesting candidates for further functional investigations to shed light on the evolution of human traits.

Supplementary Material
======================

[Supplementary data](#sup1){ref-type="supplementary-material"} are available at *Genome Biology and Evolution* online.

Supplementary Material
======================

###### 

Click here for additional data file.

The authors thank Stefan Laurent, Rui Faria, Giovanni Marco Dall'Olio and Johannes Engelken for their constructive support. This work was partially supported by the Departamento Administrativo de Ciencia, Tecnología e Innovación Colciencias from Colombia, call Francisco José de Caldas 497/2009 (A.P-S.); and a grant from the Volkswagen Foundation within the initiative "Evolutionary Biology" awarded to (K.N.). The authors declare that they do not have any conflicts of interest to declare.
